In melanoma, the major driver mutations in BRAF and NRAS lead to activation of the MAPK pathway, and ERK-mediated phosphorylation of MITF has been variously reported to control its nuclear export32, stability33 and recruitment of the acetyl transferases CBP/p30034. Here, MITF is linked to melanoma.